Losartan titration versus diuretic combination in type 2 diabetic patients

被引:9
作者
de Pablos-Velasco, PL
Toral, FP
Esmatjes, JE
Fernandez-Vega, F
de la Torre, ML
Pozuelo, A
Ruilope, LM
机构
[1] Hosp 12 Octubre, Unidad Hipertens, E-28041 Madrid, Spain
[2] H Gen Gran Canaria Dr Negrin, Las Palmas Gran Canaria, Spain
[3] H Marques Valdecilla, Santander, Spain
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] Hosp Cent Asturias, Oviedo, Spain
[6] Hosp Virgen Nieves, Granada, Spain
关键词
type; 2; diabetes; arterial hypertension; losartan; microalbuminuria; angiotensin receptor antagonists;
D O I
10.1097/00004872-200204000-00030
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Methods We compared the effects of Losartan dose titration to 100 mg versus the addition of 12.5 mg of hydrochlorothiazide, in 90 type 2 diabetic patients with microalbuminuria and blood pressure > 130/85 mmHg, receiving losartan 50 mg as initial treatment during 4 weeks. Results With the first dose of losartan, systolic (SBP) and diastolic blood pressure (DBP) decreased from 154.5 (152.1 -157.5) to 144.4 (141.3-147.5) mmHg (P < 0.001) and from 91.1 (89.4-92.8) to 84.6 (82.8-86.4) mmHg (P < 0.001), with 20 patients attaining the expected goal blood pressure (< 130/85 mmHg); albuminuria decreased from 109.8 (90.5-133.3) to 83.5 (63.6-109.5) mg per 24 h (P = 0.006). Patients not attaining the target blood pressure were randomly allocated to titration or to the combination arm. After an additional 4 weeks, patients titrated exhibited a fall in SBP and DBP from 157.1 (152.7-161.5) to 142.1 (136.4-147.8) mmHg (P < 0.001) and from 92.4 (89.5-95.3) to 83.6 (81.1-86.1) mmHg (P < 0.001); albuminuria decreased from 136.3 (97.8-189.9) to 99.7 (69.3-143.4) mg per 24 h (P = 0.002). In the combination arm, there were similar reductions in SBP and DBP from 155.3 (151.5-159.1) to 139.1 (132.1-146.1) mmHg (P < 0.001) and from 92.1 (89.3-94.9) to 80.9 (77.4-84.4) mmHg (P < 0.001); while albuminuria fell from 107.7 (82.2-141.0) to 64.2 (45.9-89.9) mg per 24 h (P = 0.001). Conclusions Losartan 50 mg was effective in reducing blood pressure and albuminuria in type 2 diabetic patients. When the blood pressure target was not reached, the two strategies tested seem to contribute similarly to further reductions in blood pressure and albuminuria. J Hypertens 20:715-719 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:715 / 719
页数:5
相关论文
共 34 条
[1]   Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy [J].
Andersen, S ;
Tarnow, L ;
Rossing, P ;
Hansen, BV ;
Parving, HH .
KIDNEY INTERNATIONAL, 2000, 57 (02) :601-606
[2]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[3]   Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy [J].
Bos, H ;
Andersen, S ;
Rossing, P ;
de Zeeuw, D ;
Parving, HH ;
de Jong, PE ;
Navis, G .
KIDNEY INTERNATIONAL, 2000, 57 :S32-S37
[4]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[5]   The 1999 WHO-ISH guidelines for the management of hypertension [J].
Chalmers, J .
MEDICAL JOURNAL OF AUSTRALIA, 1999, 171 (09) :458-459
[6]   Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus [J].
Chan, JCN ;
Critchley, JAJH ;
Tomlinson, B ;
Chan, TYK ;
Cockram, CS .
AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (01) :72-80
[7]  
DEPABLOS PL, 1998, CLIN DRUG INVEST, V16, P361
[8]  
Estacio RO, 1998, AM J CARDIOL, V82, p9R
[9]   THE ANTIPROTEINURIC EFFECT OF ACE-INHIBITION MEDIATED BY INTERFERENCE IN THE RENIN-ANGIOTENSIN SYSTEM [J].
GANSEVOORT, RT ;
DEZEEUW, D ;
DEJONG, PE .
KIDNEY INTERNATIONAL, 1994, 45 (03) :861-867
[10]   SODIUM DEPLETION ENHANCES THE ANTIPROTEINURIC EFFECT OF ACE INHIBITION IN ESTABLISHED EXPERIMENTAL NEPHROSIS [J].
GANSEVOORT, RT ;
WAPSTRA, FH ;
WEENING, JJ ;
DEJONG, PE ;
DEZEEUW, D .
NEPHRON, 1992, 60 (02) :246-247